# Phosphate sensitivity of KPC-2: a hidden variable in β-lactamase kinetics

**Authors:** Dignite F. Ngango, André Birgy, Timothy Palzkill

PMC · DOI: 10.1128/aac.01069-25 · Antimicrobial Agents and Chemotherapy · 2026-01-30

## TL;DR

Phosphate buffers can inhibit KPC-2 enzyme activity, affecting how well β-lactam antibiotics work and how enzyme studies are interpreted.

## Contribution

Phosphate is identified as a competitive inhibitor of KPC-2, with implications for β-lactamase assay accuracy.

## Key findings

- Phosphate acts as a competitive inhibitor of KPC-2, reducing its catalytic efficiency.
- The inhibitory effect is mediated through threonine 237, which is absent in less sensitive enzymes like CTX-M-14 and TEM-1.
- Phosphate binding at the active site primarily impairs substrate affinity and may reduce catalytic turnover.

## Abstract

The catalytic activity of β-lactamases, particularly class A enzymes like KPC-2, is central to β-lactam antibiotic resistance. While phosphate buffers are widely used in enzymatic assays due to their physiological relevance, their potential to interfere with enzyme function remains underappreciated. Here, we demonstrate that phosphate acts as a competitive inhibitor of KPC-2 β-lactamase, significantly reducing catalytic efficiency in a concentration-dependent manner. This inhibition is mediated through interactions with threonine 237, as substitution with glycine (T237G) abolishes the inhibitory effect. In contrast, CTX-M-14 and TEM-1, which possess serine and alanine at the same position, respectively, exhibit minimal phosphate sensitivity, underscoring enzyme-specific buffer effects. Structural and kinetic analyses indicate that phosphate binding at the active site primarily impairs substrate affinity and, in some cases, also reduces catalytic turnover. These findings highlight the potential impact of buffer selection in β-lactamase assays and suggest that phosphate-mediated inhibition may lead to underestimation of enzyme activity and inhibitor potency, particularly in studies involving KPC-2. Standardizing assay conditions is essential for accurate evaluation of β-lactamase function and resistance mechanisms.

## Linked entities

- **Proteins:** UBAC1 (UBA domain containing 1), CD248 (CD248 molecule)
- **Chemicals:** phosphate (PubChem CID 1061)

## Full-text entities

- **Genes:** UBAC1 (UBA domain containing 1) [NCBI Gene 10422] {aka GBDR1, KPC2, UBADC1}, CD248 (CD248 molecule) [NCBI Gene 57124] {aka CD164L1, TEM1}
- **Chemicals:** Phosphate (MESH:D010710), CTX-M-14 (-), beta-lactam (MESH:D047090)
- **Mutations:** T237G

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12959137/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12959137/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12959137/full.md

---
Source: https://tomesphere.com/paper/PMC12959137